From: Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
OS of all patients | EFS of all patients | |||
---|---|---|---|---|
Univariate analysis | ||||
Risk factors | HR (95% CI) | P | HR (95% CI) | P |
≤36 months | 4.40 (1.95–9.93) | 0.000 | 3.42 (1.72–6.79) | 0.000 |
High-risk | 4.46(1.97–10.09) | 0.000 | 2.50 (1.19–5.28) | 0.016 |
CD56 positivity | 1.77 (0.79–3.96) | 0.164 | 1.21(0.61–2.41) | 0.581 |
WBC ≥ 50 × 109/L | 1.17(0.50–2.74) | 0.716 | 1.13(0.55–2.34) | 0.736 |
AML1-ETO | 0.38(0.13–1.10) | 0.074 | 0.25(0.09–0.72) | 0.010 |
FLT3-ITD | 0.04(0.00–32.01) | 0.353 | 1.33(0.41–4.37) | 0.636 |
Complex karyotype | 3.34(1.32–8.44) | 0.011 | 2.04(0.84–4.95) | 0.177 |
Multivariate analysis | ||||
Risk factors | HR (95% CI) | P | HR (95% CI) | P |
≤36 months | 2.85(1.08–7.50) | 0.034 | 2.97(1.13–7.82) | 0.028 |
High-risk | 2.98(1.25–7.10) | 0.013 | 2.74(1.15–6.56) | 0.023 |
AML1-ETO | 0.70(0.21–2.37) | 0.570 | 0.56(0.21–2.35) | 0.562 |
Complex karyotype | 1.54(0.54–4.42) | 0.420 | 1.25(0.47–3.33) | 0.660 |